Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 41
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Next Generation Non-Seeing Eye Prosthesis

This project aims to push the current state of the art in ocular prothestics by integrating a small system of...

Developing a new treatment for Ebola Virus Disease

Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

Viral Causes of Lung Cancer

We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

Backer Badge Funded